ICZOOM answers shareholder questions ahead of Aug. 14 extraordinary meeting
IZM•Why the company is seeking approval
Q&A flags Nasdaq’s US$1 minimum bid-price rule as a key rationale; the record date is July 24, 2026, with 8,188,610 Class A shares and 3,829,500 Class B shares outstanding.
Extraordinary meeting set for Aug. 14
ICZOOM set an Aug. 14, 2026 extraordinary shareholder meeting to vote on two share-consolidation proposals.
- Proposal 1 seeks a 1-for-5 reverse split for Class A and Class B shares, lifting par value to US$0.8 from US$0.16.
- Proposal 2 would authorize a further reverse split of the post-split shares, with a 1-for-2 to 1-for-10 range set by Feb. 10, 2027.
- The board recommends votes “for” both proposals; passage requires a simple majority of votes cast, with Class B carrying 10 votes per share.
Related News
20/20 Biolabs Participates In Bio Asia-Taiwan And Meets With Strategic Counterparties In Taipei, Tokyo, And Seoul To Advance East Asia Roll-Up Strategy
AIDX•
Bladex declares quarterly cash dividend of US$ 0.69 per share for Q2 2026
BLX•
